miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model - Wikidata - thesis-toulmin - TriplyDB

miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model

miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model

http://www.wikidata.org/entity/Q36471327

about

MicroRNA-155 and Its Role in Malignant Hematopoiesis The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune Regulation of class IIa HDAC activities: it is not only matter of subcellular localization MicroRNA-155 expression is independently predictive of outcome in chordoma.HDAC4 is expressed on multiple T cell lineages but dispensable for their development and function.MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia MicroRNA regulation of bovine monocyte inflammatory and metabolic networks in an in vivo infection model.HDAC4: mechanism of regulation and biological functions Divergence of transcriptional landscape occurs early in B cell activation.The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote T(H)17 cell-dependent emphysema miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer.The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2 Deacetylation by SIRT1 Reprograms Inflammation and Cancer Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy.Aberrant microRNA expression in multiple myeloma.The multiple roles of microRNA-155 in oncogenesis.The pivotal role of microRNA-155 in the control of cancer.Role of miR-155 in drug resistance of breast cancer.Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases.Physiological roles of miR-155.Mutual interaction between BCL6 and miRNAs contributing to the pathogenesis of various cancers.Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue--from (auto)antigen driven selection to the activation of NF-κB signaling.miR-155 effectively induces apoptosis in K562 Philadelphia positive cell line through upregulation of p27kip1.Metal-dependent Deacetylases: Cancer and Epigenetic Regulators The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma.miR-155 Regulates Glioma Cells Invasion and Chemosensitivity by p38 Isforms In Vitro.Prognostic Value of miRNA-155 Expression in B-Cell Non-Hodgkin Lymphoma.Interplay between the miRNome and the epigenetic machinery: Implications in health and disease.MicroRNAs as regulators of drug abuse and immunity.The dichotomous nature of T helper 17 cells.Reprogramming immune responses via microRNA modulation.MicroRNA in Glioblastoma: An Overview.Oncogenic role of microRNA-155 in mycosis fungoides: an in vitro and xenograft mouse model study.miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis.Epigenetics and MicroRNAs in Cancer.miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells.

P2860

Q26777530-87C3D3B0-80BB-482D-AF37-AB5C5318A348 Q26822987-22AD9D87-3687-47A7-8B6B-75751180A39C Q27013740-A05E98B5-8417-4D05-99D5-124E3283657C Q28077331-0CB78BAB-82F0-4D4B-B715-23245180A627 Q33275600-BF5F4A92-C366-4D0A-A420-B7BED90B045E Q33566569-78348451-FE93-4D36-8536-62E4CAEB5F03 Q33612847-7A6BF799-2741-4A99-9702-FAF61ED6CA14 Q33785010-F0F2D1A3-217E-4DC3-8DFB-B6E5F0440D59 Q34039987-8477FC3D-4412-42D3-BCA6-0C6EC5534F99 Q35615412-DB8DBADF-903D-4D59-A6D1-AEFD595D3FB8 Q36134550-68230028-B7DA-4C29-A354-A93E90F07834 Q36297213-67455E3F-9A4C-4DEB-9563-D4354535C773 Q36309555-92610DDE-9C79-47E1-AC6D-6E7C50DED6D6 Q36541517-658AB670-0181-4396-B1A1-FA9458BDBF03 Q36791194-8A49CC67-7652-44F4-9842-75F9C9F56229 Q37150502-580520BF-1701-44C6-8B5C-9460C8873F00 Q37249131-78945790-6B1E-4936-8D58-C4F547F09641 Q38099048-E351F6B7-8E76-4184-947C-54F184755D84 Q38145349-D722E125-6129-4883-96ED-4216F7B93760 Q38152297-4F0CC3EF-B828-44B7-82B1-6EE950736C2B Q38368383-CC3AA0D6-B432-4E0B-A73B-133BABED715F Q38376048-B76BB32A-2608-449E-8EDA-C656D067080B Q38398527-FE664797-BB48-4F24-A63F-4B0EEAB94F29 Q38537155-72DE253B-3834-4EA0-9499-846232A8FA1A Q38649807-9EA5CFDE-030F-4C42-ACD9-C6FB49F81100 Q38696228-2ED6FD71-B930-4C4A-A024-A6A13AD2A811 Q38747135-D095B11B-A110-4FCC-B8C9-819068D8A789 Q38910415-0E253E3F-ED77-4A9B-B25C-4E1B2988BB13 Q38925936-E9F2652F-5D9F-4B71-816E-B5856FC1CB38 Q38985907-E6B25E22-04D5-4B64-BC96-009B6C4DCF6E Q39098623-FD06B60C-A41F-46DB-B56F-49C1DDB887CA Q39268245-0A69BF2F-D41B-4C7F-9F0C-B48F9E8E8E27 Q39337496-1714D4D5-A614-4A3F-8129-8C1DFE5D6D95 Q42925805-4173D5D2-DA39-4052-AE6F-886C15B1552D Q47142132-4BFFB616-529C-4F50-9869-B3610D5BE219 Q48167908-16BE4974-F48B-4611-9BF0-A7D6EC94CC26 Q49544999-B969BE60-AD36-40FA-9716-6A00E2CF82C5 Q49893204-7E19D0DE-56D2-4F03-8D4E-1C746B9036C1 Q51770872-CE5485FC-68A0-41D2-9F7D-A758024B22E0 Q53125127-35901F06-7683-4442-80DC-35BC7A13C3D5

P2860

miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model

http://www.wikidata.org/entity/Q36471327

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

miR-155 targets histone deacet ...... miR-155 transgenic mouse model

@ast

miR-155 targets histone deacet ...... miR-155 transgenic mouse model

@en

type

label

miR-155 targets histone deacet ...... miR-155 transgenic mouse model

@ast

miR-155 targets histone deacet ...... miR-155 transgenic mouse model

@en

prefLabel

miR-155 targets histone deacet ...... miR-155 transgenic mouse model

@ast

miR-155 targets histone deacet ...... miR-155 transgenic mouse model

@en

P1433

Q36471327-72A2BF7F-605F-434D-B0A7-37A23CB02E28

P1476

Q36471327-48A5BD81-0181-40B7-B7EA-9877D88E3422

P2093

Q36471327-2207C2E9-0D02-4CC6-BAF3-F787475E2A81

Q36471327-373B83BE-561A-48E6-93FC-DE393588116B

Q36471327-82CFC617-E2B7-4F70-90CD-457037B0F6C7

Q36471327-DCFCA93E-BDFC-458C-91A0-2B6015931BC5

Q36471327-F73EB7AD-7BE7-46A3-AB4D-C2636B52B087

Q36471327-FB1D8792-52BB-41D2-9093-65057373B86E

Q36471327-FEF8C563-F4C1-4D84-8F2B-9215E696D061

P2860

Q36471327-0FE94D33-5589-4D9A-9AC2-33788224DFD8

Q36471327-18CE1B09-83D8-41EE-BE24-53C450EE4456

Q36471327-1C3024A9-C1E5-4EAF-B89B-4AEB5B82C729

Q36471327-1C96E99A-7025-481C-82E2-F6B8135C041D

Q36471327-277E4CDB-1D6B-4477-B784-6C921AC0B9AE

Q36471327-27886677-864F-4A8E-A098-27EFF66D9BE6

Q36471327-2D0C1C45-A418-4F38-BF98-3B6E10BA263E

Q36471327-2DCFBC67-FADE-4723-B5F6-DB7240BE95F6

Q36471327-2F13B65A-60BE-4F0D-BA7F-A3CF45F83304

Q36471327-3D9034B2-34FC-43AF-A7F2-2F9FCB1B2BF4

P304

Q36471327-CB7EB107-CDB8-4EA0-B5CA-0183DAECB874

P31

Q36471327-8de7bf6f-62e9-4de8-9cdd-c294dd4a379f

Q36471327-9B20DED9-BBD5-4527-B970-0923EECDDDA6

P356

Q36471327-52CC292D-D80A-402C-927B-AE58222C5D7D

P407

Q36471327-7CCBBE0E-38CF-4A73-890D-4A8D189FCD27

P433

Q36471327-C7258A00-A6FC-4512-A4E5-736FB5D82A81

P478

Q36471327-D9AAE853-580B-43DB-BB38-3E9148B02A94

P50

Q36471327-1095203A-1DA6-4016-9419-11C6441DD0BD

Q36471327-2EC93372-E8CF-46E6-98D7-A5E4A6BBBEEA

Q36471327-756710B2-1179-47DC-8D84-B8A90404BEDD

Q36471327-A1D89FF9-D424-4516-ADE4-A9495A48957D

P577

Q36471327-4EFF6C65-0FA1-40F1-924E-E1F658D2CF29

P5875

Q36471327-5E0CD75A-5762-425A-B871-24DB3ED7D8D9

P698

Q36471327-6CBB89EB-4AB3-4409-9239-1350592D335A

P932

Q36471327-EC5B0553-F4B6-4D19-B231-504F4E179493

P356

PNAS.1213764109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

miR-155 targets histone deacet ...... miR-155 transgenic mouse model

@en

P2093

Danilo Perrotti

http://www.w3.org/2001/XMLSchema#string

Mark R Parthun

http://www.w3.org/2001/XMLSchema#string

Ramasamy Santhanam

http://www.w3.org/2001/XMLSchema#string

Ramiro Garzon

http://www.w3.org/2001/XMLSchema#string

Reid Neinast

http://www.w3.org/2001/XMLSchema#string

Stefan Costinean

http://www.w3.org/2001/XMLSchema#string

Sukhinder K Sandhu

http://www.w3.org/2001/XMLSchema#string

P2860

Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor

A large-scale RNAi screen in human cells identifies new components of the p53 pathway

Analysis of BCL6-interacting proteins by tandem mass spectrometry

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma

Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder

Requirement of bic/microRNA-155 for normal immune function

B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element

MicroRNA signatures in human cancers

The consensus coding sequences of human breast and colorectal cancers

P304

20047-20052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1213764109

http://www.w3.org/2001/XMLSchema#string

P407

P433

49

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Volinia

Carlo Maria Croce

P577

2012-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233738599

http://www.w3.org/2001/XMLSchema#string

P698

23169640

http://www.w3.org/2001/XMLSchema#string

P932

3523868

http://www.w3.org/2001/XMLSchema#string